Celcuity Inc.CELC

NasdaqHealthcareServices-Medical Laboratories
Price (close)
$79.52
Market cap
$3.9B
P/E
—
Revenue (TTM)
—
Net income
-$226.5M
Dividend yield
—
1-year total return
53.1%
Net margin
—
Revenue growth
—
Debt / equity
—

What Celcuity Inc. does.

and similar references refer to Celcuity Inc., a Delaware corporation. We own various unregistered trademarks and service marks, including

our corporate logo. Solely for convenience, the trademarks, trade names and service marks in this Annual Report, including those owned

not be construed as any indicator that the owner of such trademarks, trade names and service marks will not assert, to the fullest extent

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Net income-$9.5M-$29.6M-$40.4M-$63.8M-$111.8M-$177.0M
Free cash flow-$7.2M-$20.4M-$36.2M-$53.9M-$83.7M-$153.5M

More on CELC.

Figures from Celcuity Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.